Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

9 In addition to its application in infectious diseases, there are several CRISPR-based developments for the diagnosis of other diseases, including cancer, where it is being used to detect cancer ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still ... in Beijing and his colleagues used CRISPR to create the mice, using a novel ...

The company, which secured $200 million from investors in a private funding deal last week, learned Tuesday of a serious side effect experienced by one participant on a high dose of its Rett therapy.

JANUARY 22, 2025 — A review article about the future of neuromorphic computing by a team of 23 researchers, including two authors from UTSA, was published today in Nature ... that can be deployed in ...

The CRISPR/Cas9 technology is among the most exciting developments in biotechnology in recent years, a revolutionary technique which will allow faulty genes linked to any inherited disease to be ...

WASHINGTON, Jan 20 (Reuters) - President Donald Trump issued an order on Monday for the U.S. to resume processing export permit applications for new liquefied natural gas (LNG) projects ...

Nature-based health and therapy (NBHT) is a term incorporating a broad suite ... However, there are multiple challenges in aspects of NBHT research and application, from methodological issues in the ...